Keyphrases
Voriconazole
85%
Gemcitabine
85%
Pharmacokinetics
59%
Hematopoietic Cell Transplantation
51%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
51%
Neurofibromatosis Type I
51%
Neurofibromatosis Type 1 (NF-1)
51%
Human Serum
37%
Solid-phase Extraction
36%
Pediatric Patients
34%
Scopolamine
34%
In Vitro Cell Culture
34%
Bioreactor System
34%
Pediatric
27%
Clinically Significant
26%
Pharmacokinetic Variability
25%
High-performance Liquid Chromatography
25%
Non-small Cell Lung Cancer (NSCLC)
25%
Human Plasma
22%
Serum Samples
22%
Dose Finding
21%
Haematopoietic Stem Cell Transplant Recipients
21%
Mini-pig Model
20%
Minipig
20%
Mobile Phase
20%
CYP2C19 Polymorphism
20%
MS Method
20%
Limit of Quantification
19%
Pharmacodynamics
19%
Acid Concentration
18%
Cytotoxicity
18%
Sensitive Determination
17%
Fentanyl
17%
Healthy Individuals
17%
Clinical Features
17%
Fenofibric Acid
17%
Within-individual
17%
Levetiracetam
17%
SLC28A3
17%
Obesity
17%
Initial Dose
17%
Anion Exchange
17%
CYP51
17%
Sensitivity Method
17%
Hepatotoxicity
17%
C-reactive Protein
17%
Enhanced Sensitivity
17%
Predictive Value
17%
Albumin
17%
Genetic Engineering
17%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Voriconazole
85%
Gemcitabine
85%
Cell Culture
38%
Scopolamine
34%
Cytotoxicity
34%
High Performance Liquid Chromatography
27%
Non Small Cell Lung Cancer
25%
Pharmacodynamics
22%
CYP2C19
22%
Transdermal
19%
Normal Human
17%
Drug Delivery System
17%
Duragesic
17%
Minipig
17%
Hepatotoxicity
17%
Fenofibric Acid
17%
Solid Malignant Neoplasm
17%
Selumetinib
17%
C Reactive Protein
17%
Neurofibromatosis Type 1
17%
Epidermal Growth Factor Receptor Kinase Inhibitor
17%
Sunitinib
17%
Bone Cement
17%
Levetiracetam
17%
ABCG2
17%
Tissue Culture Medium
17%
Renal Cell Carcinoma
17%
Zoledronic Acid
17%
Giant Cell Tumor
17%
Multiple Myeloma
17%
Efavirenz
17%
Tenofovir
17%
Lamivudine
17%
Dolutegravir
17%
Acetonitrile
10%
Transdermal Delivery
9%
Pyrrole Derivative
8%
Clinical Trial
8%
Formate
8%
Cytidine Deaminase
8%
Pharmacokinetic Parameter
7%
Flow Cytometry
7%
Antifungal Agent
7%
Drug Analysis
6%
Non-Steroidal Anti-Inflammatory Drug
6%
Therapeutic Window
5%
Protein Tyrosine Kinase Inhibitor
5%
Dasatinib
5%
Systemic Mycosis
5%